Registration is now open for RNA Therapeutics 2021
            
            	
            
            
             
 SMi Group are delighted to announce their 12th annual conference RNA Therapeutics, taking place on 10th - 11th February 2021. 
 
  
            
			- (1888PressRelease) October 10, 2020 - The 2021 conference is set to explore the latest developments in RNA delivery agents and RNA-based therapeutics with the latest case studies on advanced mRNA technologies, oligonucleotide delivery, therapeutic applications and future trends and innovations.  
 
 NEW ADDITION TO THIS YEARS AGENDA!
 
 The 2021 programme includes the new Focus Day on the 12th February which focuses on RNA Interference. Chaired by Shalini Andersson, Chief Scientist New Therapeutic Modalities & Head of Oligonucleotide Discovery, AstraZeneca.
 
 Panel discussion on COVID-19: how has the RNA industry adapted to beat the pandemic
 
 Delegates stand to gain many valuable insights from this event such as:
 	Industry insights into how mRNA is being used to combat COVID-19
 	Case studies exploring the growing therapeutic potential of RNA for rare diseases
 	Future trends in AI application for optimal RNA therapeutics
 	A regulatory outlook of the RNA landscape, clinical trials and looking ahead
 
 Visit the website for more details: www.therapeutics-rna.com/1888pr1
 
 CHAIR FOR 2021:
 Heinrich Haas, VP RNA Formulation and Drug Delivery, BioNTech
 
 Focus Day Chair for 2021: Shalini Andersson, Chief Scientist New Therapeutic Modalities & Head of Oligonucleotide Discovery, AstraZeneca
 
 KEY SPEAKERS:
 	Dong Yu, Fellow, Senior Director, and Head, GSK Vaccines
 	Maria Luisa Pineda, CEO and Co-Founder, Envisagenics
 	Kirsty Wydenbach, Deputy Unit Manager/Senior Medical Assessor, MHRA
 	Dong Ki Lee, CEO, OliX
 	Jennifer Pluim, Vice President Medical Affairs, ProQR
 	Arpan Desai, Team Leader, Advanced Drug Delivery, Pharmaceutical Sciences, AstraZeneca
 	Ruchi Shah, Senior Research Engineer, New Therapeutics Modalities, Eli Lilly and Company
 	Michael Mulqueen, Vice President Business Development, eTheRNA immunotherapies
 	Troels Koch, Founder & CEO, Aqiventa
 
 Further details about our speakers can be found here: www.therapeutics-rna.com/1888pr1
 Proudly sponsored by: Thermo Fisher Scientific
 
 Contact Information:
 For media enquiries contact Jinna Sidhu on Tel: +44 (0)20 7827 6088 / Email:  hsidhu ( @ ) smi-online dot co dot uk
 
 About SMi Group:
 Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the worlds most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
 
 ###
space
             
			
			
         
        
        space